Newbridge Financial Services Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$8.97K | – | 1226 |
|
|
2024
Q1 | $8.97K | Hold |
1,000
| – | – | ﹤0.01% | 796 |
|
|
2023
Q4 | $11.2K | Hold |
1,000
| – | – | 0.01% | 710 |
|
|
2023
Q3 | $8.63K | Hold |
1,000
| – | – | ﹤0.01% | 853 |
|
|
2023
Q2 | $10.4K | Sell |
1,000
-1,000
| -50% | -$10.4K | 0.01% | 882 |
|
|
2023
Q1 | $21.7K | Hold |
2,000
| – | – | 0.01% | 683 |
|
|
2022
Q4 | $22.4K | Hold |
2,000
| – | – | 0.01% | 683 |
|
|
2022
Q3 | $20K | Hold |
2,000
| – | – | 0.01% | 699 |
|
|
2022
Q2 | $18K | Hold |
2,000
| – | – | 0.01% | 693 |
|
|
2022
Q1 | $19K | Hold |
2,000
| – | – | 0.01% | 750 |
|
|
2021
Q4 | $22K | Hold |
2,000
| – | – | 0.01% | 702 |
|
|
2021
Q3 | $15K | Hold |
2,000
| – | – | 0.01% | 755 |
|
|
2021
Q2 | $29K | Buy |
+2,000
| New | +$29K | 0.02% | 658 |
|